What is the therapeutic window between GCS inhibition efficacy and systemic toxicity in GBA-PD patients?

Analysis ID: SDA-2026-04-11-gap-debate-20260410-111106-df334a52 | Domain: neurodegeneration | Status: failed | Created: 2026-04-11T07:28:04.503723

Top Hypotheses (0 total)

No hypotheses yet